Syringe Driver Survey Database migration to MedicinesComplete - January 2023

Syringe Driver Survey Database has moved to MedicinesComplete and is no longer available on palliativedrugs.com.

It has been renamed to PCF’s Syringe Driver Database and is now accessed through Drug Compatibility Checker.

Drug Compatibility Checker, through MedicinesComplete is a new tool providing essential compatibility knowledge to support the administration of injectable drugs combining published data and clinical practice reports.

Find out more about Drug Compatibility Checker:https://about.medicinescomplete.com/publication/drug-compatibility-checker/

If you have a subscription to Palliative Care Formulary through MedicinesComplete, you will have access to PCF’s Syringe Driver Database through Drug Compatibility Checker, at no charge through 2023. 

To contribute to PCF’s Syringe Driver Database please continue to submit a clinical practice report using palliativedrugs.com here: https://www.palliativedrugs.com/syringe-driver-database.html

To learn more about a subscription to the Palliative Care Formulary through MedicinesComplete, please contact us here: https://info.medicinescomplete.com/sales

If you have any questions regarding access to PCF’s Syringe Driver Database or would like to renew your subscription to Palliative Care Formulary, please contact pharmpress-support@rpharms.com.

---

Controlled drug requisition requirements and instalment prescribing

18th November 2015

From 30 November 2015, an approved form will be mandatory when requisitioning Schedule 2 and 3 controlled drugs in the community (note hospices and prisons are exempt). For England there is a new approved requisition form in electronic format that is available on the NHS Business Services Authority website. This replaces the form that is currently used in England. Scotland and Wales will continue to use the forms under their existing arrangements.

In addition, a new set of approved wording for instalment prescribing of controlled drugs has been introduced. The new set of wording is shorter in length and more flexible than the current set of approved wording. The expectation is that prescribers will take steps to move to the new set of approved wording in the coming months. However, all legal prescriptions which incorporate the old wording clearly establishing the intentions of the prescriber should continue to be accepted and dispensed, unless in the professional judgment of the pharmacist there are reasons why these prescriptions should not be accepted.

click here to view